Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Dysglycemia: full-pipeline trial registry
1 of 4 indexed Dysglycemia trials are currently recruiting.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Dysglycemia: 4 US clinical trials tracked, 1 recruiting.
Dysglycemia is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Joslin Diabetes Center, running 1 of these trials.
Enrollment posture brief
Registry condition dysglycemia
OPEN 1 | RECR 25% | LATE 1 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Dysglycemia lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Dysglycemia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Dysglycemia is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
Washington University School of Medicine
NCT05277558
Supporting Transitions to Primary Care Among Under-resourced, Postpartum Women (STEP-UP)
Northwestern University
NCT05852054
Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary Syndrome
University of California, San Francisco
NCT06050265
Metabolic Effects of Betaine Supplementation
Joslin Diabetes Center
NCT01950039
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Dysglycemia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Dysglycemia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Dysglycemia page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Dysglycemia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Joslin Diabetes Center sponsors the most Dysglycemia trials on record, review their full trial history before evaluating a specific study. See Joslin Diabetes Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Dysglycemia condition card totals 4 registered trials; most-linked intervention Betaine; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.